Anpario (LON:ANP) Announces Quarterly Earnings Results

Anpario (LON:ANP) announced its quarterly earnings data on Wednesday. The company reported GBX 22.45 EPS for the quarter, Digital Look Earnings reports. Anpario had a return on equity of 16.88% and a net margin of 14.31%.

Anpario Stock Down 2.8%

Shares of LON ANP traded down GBX 13.50 during midday trading on Thursday, reaching GBX 466.50. 73,137 shares of the company’s stock traded hands, compared to its average volume of 45,578. The company has a market cap of £75.97 million, a price-to-earnings ratio of 12.30 and a beta of 1.08. The stock’s 50 day simple moving average is GBX 531.50 and its 200-day simple moving average is GBX 516.75. The company has a quick ratio of 5.16, a current ratio of 4.50 and a debt-to-equity ratio of 0.60. Anpario has a one year low of GBX 391.11 and a one year high of GBX 580.

Analysts Set New Price Targets

ANP has been the topic of a number of research analyst reports. Canaccord Genuity Group restated a “buy” rating and issued a GBX 570 price target on shares of Anpario in a report on Friday, June 26th. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of GBX 570.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.